| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.0074 | 0.9 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.0068 | 0.9 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.002 | 1 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | 0.21 | 0.003 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.004 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.02 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.02 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | 0.09 | 0.03 |